NASDAQ:OZEM Roundhill GLP-1 & Weight Loss ETF (OZEM) Price, Holdings, & News $25.89 -0.18 (-0.69%) As of 03:25 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock About Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OZEM alerts:Sign Up Key Stats Today's Range$25.74▼$25.9550-Day Range$23.47▼$26.8952-Week Range$20.01▼$29.21Volume14,077 shsAverage Volume13,327 shsMarket Capitalization$34.17 millionAssets Under Management$34.41 millionDividend Yield0.19%Net Expense Ratio0.59%Aggregate RatingModerate Buy ETF Overview The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill. Read More Roundhill GLP-1 & Weight Loss ETF ExpensesTypeOZEMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.59%0.57%0.56%0.54%0.53%Other Expenses0.00%0.57%0.56%0.52%0.56%Total Expense0.59%0.74%0.76%0.73%0.73%Fee Waiver0.00%-0.76%-0.66%-0.50%-0.63%Net Expense0.59%0.60%0.63%0.63%0.60% Receive OZEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roundhill GLP-1 & Weight Loss ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OZEM ETF News HeadlinesHow to avoid nausea on Ozempic and GLP-1 medicationsMarch 17, 2025 | msn.comEmployers face pressure to add coverage of Ozempic, other weight-loss drugsMarch 12, 2025 | bizjournals.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.September 10 at 2:00 AM | Brownstone Research (Ad)Here’s why Ozempic maker’s new weight-loss drug isn’t good enough for investorsMarch 10, 2025 | msn.comNaturally occurring molecule rivals Ozempic in weight loss, sidesteps side effectsMarch 7, 2025 | msn.comMore yogurt and nuts, less alcohol and snack foods: How GLP-1 medications like Ozempic are influencing people’s food spending habitsMarch 5, 2025 | yahoo.comSee More Headlines OZEM ETF - Frequently Asked Questions How have OZEM shares performed this year? Roundhill GLP-1 & Weight Loss ETF's stock was trading at $24.36 at the beginning of the year. Since then, OZEM stock has increased by 6.3% and is now trading at $25.89. Who are Roundhill GLP-1 & Weight Loss ETF's major shareholders? Roundhill GLP-1 & Weight Loss ETF's top institutional investors include Oak Family Advisors LLC (3.93%), Relyea Zuckerberg Hanson LLC (0.76%), Flow Traders U.S. LLC (0.76%) and Osaic Holdings Inc. (0.11%). How do I buy shares of Roundhill GLP-1 & Weight Loss ETF? Shares of OZEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Roundhill GLP-1 & Weight Loss ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Roundhill GLP-1 & Weight Loss ETF investors own include NVIDIA (NVDA), ARM (ARM), Berkshire Hathaway (BRK.B), Chipotle Mexican Grill (CMG), Coinbase Global (COIN), Femasys (FEMY) and Super Micro Computer (SMCI). Fund Details IssuerRoundhill Investments Fund NameRoundhill GLP-1 & Weight Loss ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:OZEM Inception Date5/21/2024 Fund ManagerWill Hershey, Tim Maloney, Dave Mazza, Drew Walsh Previous SymbolNASDAQ:OZEM WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings24 Fund Statistics Assets Under Management$34.41 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRoundhill Financial, Inc. CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerOld Mission Options OptionableOptionable Options Volume1 Put Options2 Call Options1 Short Interest33,400 shs Miscellaneous Outstanding Shares1,320,000BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report Top 10 OZEM HoldingsNovo Nordisk A/S (NYSE:NVO)Holding Weight: 19.54%Eli Lilly and Company (NYSE:LLY)Holding Weight: 15.88%Zealand Pharma A/SHolding Weight: 6.24%Roche Holding AGHolding Weight: 5.35%Chugai Pharmaceutical Co., Ltd.Holding Weight: 4.80%Innovent Biologics, Inc.Holding Weight: 4.43%Structure Therapeutics (NASDAQ:GPCR)Holding Weight: 4.42%Pfizer (NYSE:PFE)Holding Weight: 4.01%Metsera (NASDAQ:MTSR)Holding Weight: 3.87%AstraZeneca (NASDAQ:AZN)Holding Weight: 3.44%Full Holdings DetailsOZEM Sector ExposureOZEM Industry Exposure This page (NASDAQ:OZEM) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredPOP QUIZ: What’s the #1 indicator of a stock’s success? (Nope, not earnings or sales)What indicator do you think is the #1 predictor of stock market success? Most would guess earnings or sales...The Oxford Club | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OZEM Stock Alerts